A
Here’s a TL;DR background of the research on a common diabetes drug tied to longer life in women:
TL;DR – Common Diabetes Drug & ‘Exceptional Longevity’
Drug: Metformin — a widely prescribed medication for type 2 diabetes. (ScienceAlert)
Key finding: Older women with type 2 diabetes who took metformin had about a 30 % lower risk of dying before age 90 compared with those taking a different diabetes medication (sulfonylureas). (Medical Xpress)
What this suggests: Metformin might promote “exceptional longevity” — living to advanced ages such as 90 or older — possibly by influencing biological aging pathways beyond blood‑sugar control. (New Atlas)
How the study was done: It analysed long‑term data from postmenopausal women with diabetes, comparing outcomes between those on metformin and those on other drugs. (Medical Xpress)
Caveats: This research shows an association, not definitive proof that metformin causes longer life; more controlled studies are needed to understand mechanisms. (today.ucsd.edu)
Bottom line: Metformin — a cheap, common diabetes drug — is linked in research to improved chances of living into advanced age for women with type 2 diabetes, sparking interest in its potential anti‑aging effects. (ScienceAlert)
Would you like a bullet‑point summary of the possible biological reasons scientists think metformin might affect aging? (It ties into why this finding matters.)
No comments:
Post a Comment